Series C - Memo Therapeutics
Investment Firm
Overview
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
Announced Date
Nov 02, 2023
Closed on Date
Nov 02, 2023
Funding Type
Series C
Highlights
Location
Switzerland, Europe
Social
Participant Investors
9
Round Details and Background
Memo Therapeutics raised $27587120 on 2023-11-02 in Series C
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 16, 2022 |  Series B - Memo Therapeutics | 8 | - | 24.9M |
| Nov 02, 2023 | Series C - Memo Therapeutics | 9 | - | 27.6M |
| May 07, 2024 | Series C - Memo Therapeutics | 2 | - | 22.0M |
| Jul 22, 2015 | Series A - Memo Therapeutics | 3 | - | 2.3M |
Recent Activity
There is no recent news or activity for this profile.